Cargando…
Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
BACKGROUND: We evaluated quality of life among subjects with upper- and lower-limb spasticity who received escalating doses of incobotulinumtoxinA (total body doses up to 800 U) in the prospective, single-arm, dose-titration TOWER study. METHODS: In this exploratory trial, subjects (N = 155; 18–80 y...
Autores principales: | Fheodoroff, Klemens, Rekand, Tiina, Medeiros, Luisa, Koßmehl, Peter, Wissel, Jörg, Bensmail, Djamel, Scheschonka, Astrid, Flatau-Baqué, Birgit, Simon, Olivier, Dressler, Dirk, Simpson, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055124/ https://www.ncbi.nlm.nih.gov/pubmed/32131842 http://dx.doi.org/10.1186/s12955-020-01304-4 |
Ejemplares similares
-
Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study
por: Wissel, Jörg, et al.
Publicado: (2017) -
Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
por: Wissel, Jörg, et al.
Publicado: (2021) -
Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children: SIPEXI
por: Berweck, Steffen, et al.
Publicado: (2021) -
Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
por: Albanese, Alberto, et al.
Publicado: (2023) -
Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects
por: Masakado, Yoshihisa, et al.
Publicado: (2022)